Moving exercise research in multiple sclerosis forward (the MoXFo initiative): developing consensus statements for research by Dalgas, Ulrik et al.
Moving Exercise Research in Multiple Sclerosis Forward (the MoXFo initiative): Developing 
Consensus Statements for Research. 
  
Dalgas U
1
, Hvid LG
1
, Kwakkel G
2,3
, Motl RW
4
,
 
De Groot V
2
, Feys P
5
, Eijnde BO
5
, Coote S
6
, 
Beckerman H
2
, Pfeifer K
7
, Streber R
7,8
, Peters S
8
, Riemann-Lorenz K
9
, Rosenkranz SC
9,10
, 
Centonze D
11
, Van Asch P
12
, Bansi J
13
, Sandroff BM
4
, Pilutti LA
14
, Ploughman M
15
, Freeman J
16
, 
Paul L
17
, Dawes H
18
, Romberg A
19
, Kalron A
20,21
, Stellman JP
22,23
, Friese MA
9
 & Heesen C
9,10
 
1 Section for Sport Science, Department of Public Health, Aarhus University, Denmark 
2 Department of Rehabilitation Medicine, Amsterdam University Medical Centers, Vrije Universiteit, MS Center Amsterdam, Amsterdam Movement 
Sciences, Amsterdam Neuroscience, Amsterdam University Medical Centre, The Netherlands  
3 Department of Physical Therapy and Human Movement Sciences, Northwestern University, Chicago, USA. 
4 Department of Physical Therapy, University of Alabama at Birmingham, Birmingham, AL, USA 
5 REVAL Rehabilitation Research Center, BIOMED Biomedical Research Institute, Faculty of Rehabilitation Sciences, Hasselt University, Belgium 
6 Faculty of Education and Health Sciences, School of Allied Health, University of Limerick, Limerick, Ireland 
7 Department of Sport Science, Division Exercise and Health, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany. 
8 Deutscher Verband für Gesundheitssport und Sporttherapie e. V. (DVGS), Hürth, Germany 
9 Institut für Neuroimmunologie und Multiple Sklerose, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany 
10 Klinik und Poliklinik für Neurologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany 
11 Unit of Neurology, IRCCS Neuromed, Pozzilli (IS), Italy 
12 Fit Up Physiotherapy Centre Kontich, Kontich, Belgium 
13 Deparment of Neurology, Kliniken-Valens, Rehabilitationsklinik-Valens, Valens, Switzerland 
14 Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada 
15 Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada. 
16 Faculty of Health: Medicine, Dentistry and Human Sciences, University of Plymouth 
17 School of Health and Life Sciences , Glasgow Caledonian University , Glasgow , UK  
18 Movement Science group, School of Life Sciences, Oxford Brookes University, Headington, Oxford, UK 
19 Masku Neurological Rehabilitation Centre, Masku, Finland 
20 Department of Physical Therapy, Sackler Faculty of Medicine, School of Health Professions, Tel-Aviv University, Tel Aviv, Israel 
21 Sagol School of Neurosciences, Tel-Aviv University, Tel Aviv, Israel 
22 APHM, Hopital de la Timone, CEMEREM, Marseille, France 
23 Aix Marseille Univ, CNRS, CRMBM, UMR 7339, Marseille, France 
 
 
Running title: Moving MS Exercise forward 
 
Keywords: Consensus, exercise, rehabilitation, recommendations, multiple sclerosis 
Corresponding Author 
Ulrik Dalgas 
Section of Sport Science 
Dep. Public Health 
Aarhus University 
Denmark 
Tel: +45 40123039 
e-mail: dalgas@ph.au.dk 
  
Abstract 
Exercise as a subset of physical activity is a cornerstone in the management of multiple sclerosis 
(MS) based on its pleotropic effects. There is an exponential increase in the quantity of research on 
exercise in MS, yet a number of barriers associated with study content and quality hamper rapid 
progress in the field. To address these barriers and accelerate discovery, a new international 
partnership of MS-related experts in exercise has emerged with the goal of advancing the research 
agenda. As a first step, the expert panel met in May 2018 and identified the most urgent areas for 
moving the field forward, and discussed the framework for such a process. This led to identification 
of five themes, namely “Definitions and terminology”, “Study methodology”, “Reporting and 
outcomes”, “Adherence to exercise”, and “Mechanisms of action”. Based on the identified themes, 
five expert groups have been formed, that will further (a) outline the challenges per theme and (b) 
provide recommendations for moving forward. We aim to involve and collaborate with people with 
MS / MS organizations (e.g. Multiple Sclerosis International Federation (MSIF) and European 
Multiple Sclerosis Platform (EMSP)) in all of these five themes. The generation of this thematic 
framework with multi-expert perspectives can bolster the quality and scope of exercise studies in 
MS that may ultimately improve the daily lives of people with MS.     
  
Introduction 
For many years, exercise was a controversial intervention in multiple sclerosis (MS) 
as it was thought to exacerbate symptoms (1). However, today ample evidence exists that exercise 
is a safe intervention that will benefit most people with MS by improving physical fitness, physical 
function, fatigue, mood, and quality of life(2, 3), along with early evidence suggesting that exercise 
may have disease modifying effects(4-6). The number of exercise studies in MS has increased 
almost exponentially since the millennium (see figure 1), having positive implications for 
researchers, clinicians, and people with MS(7), as exemplified by the development of current MS 
exercise and physical activity guidelines(8-10).  
While the existing knowledge on the effects of exercise in MS should be incorporated 
into our collective understanding of the nature and delivery of exercise interventions, some major 
issues currently limit such common understanding and implementation in clinical practice. The 
following contain examples hereof, that have also been briefly discussed in previous reviews(4, 11). 
First, important definitions and terminologies are not uniform and reporting, such as describing 
recruitment, completion procedures and participant characteristics do not conform to standards. 
Second, there is a lack of consensus on outcomes for monitoring, evaluating and reporting exercise 
interventions (i.e. current metholodical checklists appear insufficient in MS exercise trials). Third, a 
common protocol format of exercise description and performance documentation with respect to 
intensity, duration, and frequency would be helpful when estimating the proposed and applied 
program content. Fourth, consensus is required on the value of biomarkers, ranging from pure 
fitness indicators through inflammatory and neuroprotective markers. Fifth, an in-depth mechanistic 
understanding of the effects of exercise on the central nervous system (CNS) and specifically the 
brain, derived from both animal and human studies, is warranted.  Sixth, the quality of research 
informing the current MS physical activity guidelines are heterogeneous with low evidence and a 
present need to incorporate multiple aspects of physical activity prescription (e.g. effects of physical 
activity versus sedentary behavior along with potential risks thereof) (12). Seventh, the majority of 
published studies have been small numbered (and with that underpowered), evaluating short-term 
exercise interventions(13) that were often biased by recruitment of participants that differed from 
the target population (e.g. already physically active, motivated, and less disabled people with MS) 
(14, 15)). Our overall understanding of long-term effects of exercise (particularly whether it is 
disease modifying (16)) and adherence to exercise are currently limited (17).  
Consequently, to optimize the outcome of future MS exercise research, it is time for a 
thorough and critical examination of the most relevant themes limiting progress in MS exercise 
research. These themes were identified at a roundtable meeting by an international expert panel, as 
has previously been done in other neurological disorders, such as stroke(18, 19). Based on the 
content of this first roundtable meeting, the aim of this paper is to (a) summarize the identified 
themes and outline a framework that will guide an updated and optimized MS exercise research 
agenda, and (b) discuss and consider if the research field is capable and ready for large, 
international multicenter efforts that would target the most important research question(s). 
 
Theme identification 
As a first step, a panel of experts from the field were invited to join a roundtable 
meeting held in Amsterdam on May 31
st 
2018. The panel comprised experts from all areas of the 
translational line, i.e. from basic animal research to real-world clinical implementation. 
Furthermore, an expert from the stroke recovery and rehabilitation task force(18, 19) (Gert 
Kwakkel) was invited to present and share experiences from a similar project undertaken in stroke 
rehabilitation. The roundtable meeting comprised two parts. During the first part, five experts 
provided brief status presentations with each of these followed by panel discussions. Topics 
included development of a stroke exercise research agenda (Gert Kwakkel), current status of MS 
exercise from a worldwide perspective (Ulrik Dalgas), key questions in exercise treatment in MS 
(Peter Feys), relevant core-set outcomes (Lorna Paul), and management of adherence (Susan 
Coote). During the second part, identification of the most relevant research questions were 
discussed, along with examination of potential study designs of future large, international 
multicenter phase II-IV MS exercise trials.  
The meeting was recorded, and afterwards a report was drafted by the steering 
committee and revised according to comments from the expert panel. Based on the discussions, five 
overall themes were identified in which the expert panel agreed that more in-depth work was 
needed to further optimize future MS exercise research. The identified themes are outlined below. 
  
Figure 1: Literature identified per year since 1950. The search was performed on November 3rd 
2019 using PubMed and the search terms ”exercise” and “multiple sclerosis” (n=2000 studies, top 
figure), along with ”exercise” and “multiple sclerosis” and “randomized controlled trial” (n=276 
studies, bottom figure). 
 
Theme 1: Definitions and Terminology 
Consensus regarding definitions and terms used in MS exercise is lacking. For 
example, several terms are often used interchangeably, such as “exercise” and “rehabilitation” and 
“physical activity”, “inactivity” and “sedentary” and “low fitness”, as well as “neuroprotection” and 
“neuro-regeneration” and “neuroplasticity” and “disease-modification”. Furthermore, a thorough 
description of exercise interventions, in terms of frequency, intensity, time and type of activity, as 
well as description of disability-specific adaptations. Expert consensus regarding exercise 
definitions and descriptions ensures a clear understanding of the characteristics of exercise 
interventions across disciplines and accurate knowledge dissemination and translation between 
researchers, people with MS, health professionals and the public(11). One priority area is therefore, 
to outline and achieve consensus on clear definitions of important terms and concepts. This will 
further underlie the work being done within the other identified themes. 
  
Theme 2: Study methodology 
Long-term and large-scale (phase II-IV) exercise intervention trials enrolling people 
with MS are lacking(11). Indeed, the majority of published studies have evaluated short-term 
supervised exercise interventions (≤ 3 months) in small/underpowered samples (≤ 100 
participants)(13). Additional trial-design issues include conceptualization of control groups(20) and 
management of the use of mixed (potentially confounding) disease modifying medications. In 
conducting longer term trials, active comparators seem ethically necessary given the existing 
knowledge on the importance of exercise/physical activity in people with MS. Active comparators 
may likely improve overall adherence (see Theme 4) and internal validity by offering better 
isolation of the “active ingredients” of exercise.  
A critical component for large multi-national trials is access to adequately equipped 
and accessible exercise facilities (i.e. close to individual homes and/or MS clinics), along with 
involvement of qualified health personnel. Such arrangements are not always met, and alternative 
solutions, such as remote technologies, may help overcome these challenges (21). Furthermore, 
head-to-head comparisons of different exercise modalities (i.e. resistance, aerobic, balance/stability 
or combinations of these) are required in order to determine the most effective intensities, 
durations/frequencies, and progression models in context of the targeted outcomes. Also, people 
with MS may adapt differently to exercise depending on the type and stage of MS (relapsing-
remitting versus progressive, early versus late phase) and level of disability (ambulatory or non-
ambulatory). For example, surprisingly little is known about the effects of exercise in the very early 
phase of MS.  Taken together, important issues related to study methodology still remain to be 
addressed in future exercise trials. If ameliorated, the challenges and solutions identified within this 
theme may form the foundation for designing a large aspirational multicenter (phase III) 
effectiveness trial with higher dosing and longer follow up, along with better stratification and more 
serial assessments over time.  
 
Theme 3: Reporting and Outcomes 
Lack of a standardized approach when performing measurements and reporting 
outcomes in MS exercise trials hampers the ability to advance our understanding of exercise effects, 
limits the advice that can be given to people with MS, and impairs consolidated knowledge from 
research using meta-analyses. Improved reporting may be obtained by adapting and promoting 
existing recommendations such as the TIDieR checklist(22), the Consensus on Exercise Reporting 
Template(23), and other guidelines(24). Acknowledging that the choice of outcomes depends on the 
primary aim of a study, the clinimetric properties of the outcome should always be appropriate to 
discriminate, predict, or evaluate (i.e. responsive). To further advance a more uniform outcome 
approach, application of the Core Outcome Measures in Effectiveness Trials - (COMET) 
(http://www.comet-initiative.org/) and/or the COnsensus-based Standards for the selection of health 
Measurement INstruments - (COSMIN) (https://www.cosmin.nl/) methodology seems relevant. In 
addition, a thorough report of the minimally clinical important change values of trial outcomes is 
needed and confirmation whether the values are consistent across disability levels. Since recent 
work has suggested that typically employed methodological checklists, such as CONSORT and 
TIDieR, may be insufficient in exercise trials, development of specific checklists seem 
warranted(25). Methods to measure and report daily physical activity levels, such as questionnaires 
and accelerometry, is another pressing issue in which no consensus exists. Consensus regarding 
optimal outcome measures to include in exercise trials (e.g. motor, cognitive, quality of life, adverse 
events) is warranted including quantification of activity and participation which arguably have the 
greatest degree of ecological validity. Importantly, people with MS should be involved in the 
process of selecting relevant outcomes (further information in section ‘Moving forward’).  A 
previously published paper on recommended core outcomes in MS exercise studies (26), provides a 
suitable starting point in order to update outcomes, report psychometric properties and add relevant 
biomarkers such as imaging (e.g. MRI) and biological samples (e.g. cytokines, neurotrophins). 
   
Theme 4: Adherence and compliance to exercise 
In exercise studies, “compliance” is often used interchangeably with “adherence”, 
when in fact, they are related but different constructs. Compliance is the extent to which the 
parameters of people with MS's behavior match the prescriber's recommendations(27) whereas 
adherence refers to the extent to which the participant continues with the practice or behavior as 
agreed(27). The “Rehabilitation in MS” (RIMS) organization has endorsed exercise adherence as a 
major focus area(17, 28), however, both compliance (complying with the training 
parameters/protocol) and adherence (longer-term exercise and physical activity commitment and 
behavioral change) are important in order to impact health long-term.  Although psychological 
strategies that support exercise adherence have been examined, the evidence especially from e-
health-supported coaching strategies in MS, is still in its infancy(29). Related to theme 2 (see 
above), exercise adherence, assessed months or years later, is critical in order to assess the 
durability/sustainability of exercise effects from a trial design perspective. To advance our 
understanding of adherence, expert people with MS will also be engaged while addressing this 
theme. In addition, the existing adherence models(30, 31) will serve as a basis to develop future 
exercise interventions for people with MS.  
 
Theme 5: Mechanisms of action 
Understanding the underlying mechanisms that explain the beneficial effects of 
exercise in MS is fundamental in order to optimize exercise interventions in general and to tailor 
optimal interventions to single individuals. At present, the available human studies are preliminary, 
and have mainly addressed potential changes in CNS morphology and functioning (i.e. in relation to 
MRI-derived changes in volumes and activation of specific brain areas)(5) and blood biomarkers 
such as neurotrophins and inflammatory cytokines. Combining several imaging, biological, and 
neuroperformance markers in exercise trials (e.g. neurophysiology, immunology, neuropsychology, 
biomechanics, vascular changes, blood brain barrier integrity)(32) may help determine whether a 
potential treatment will be beneficial given the person’s clinical profile (personalized approach). 
Experimental studies in animal models of MS have begun to address exercise-induced changes in 
neuronal function(33), although there is still a gap in the alignment and translation to human 
studies(34). Nonetheless, basic biomedical research is essential in order to characterize the potential 
neuroprotective and reparative mechanisms of exercise in MS that cannot be (currently) examined 
in humans(33) and in this way, help inform the design of human/clinical MS studies. 
Altogether, a collective effort is needed to establish a ‘core’ list of the most appropriate biomarkers 
in MS (in alignment with Theme 3), to advance our understanding of any exercise-induced 
translational effects. Also, conceptualization on how to distinguish disease modification from 
symptomatic modification should be considered.  
 
Moving forward  
To move the field forward, five groups, overseen by a project steering committee, will 
be formed to address five identified themes. These five groups/themes will each be chaired by one 
of five different researchers and will have an additional 3-5 members from the panel as well as 1-3 
external members if needed. The steering committee will ensure overarching alignment of the work. 
We aim to establish collaboration with MS patients/organizations (e.g. Multiple Sclerosis 
International Federation (MSIF) and European Multiple Sclerosis Platform (EMSP)) to help guide 
the work within the groups/themes. Financial support will be sought to permit within and between 
group collaboration. Based on this approach, it is expected that a comprehensive, relevant and 
warranted framework can be put forth, forming the basis for improved MS exercise studies and 
further collaborative efforts within the field, ultimately seeking to improve the daily life of people 
with MS.   
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